@Sharsheret Profile picture

Sharsheret

@Sharsheret

We are the #Jewish #breastcancer and #ovariancancer organization: providing tailored support for you and your family, when and how you want it.

Similar User
MBC Alliance photo

@mbcalliance

after BREAST CANCER photo

@ABC_program_

MyBCTeam photo

@MyBCTeam

Living Beyond Breast Cancer photo

@LivingBeyondBC

@FacingOurRisk photo

@FacingOurRisk

National Breast Cancer Coalition photo

@NBCCStopBC

FdtnForWomensCancer photo

@GYNCancer

BCW Magazine photo

@BCWmagazine

Cancer Be Glammed photo

@CancerBeGlammed

Male Breast Cancer Global Alliance photo

@MBCGlobAlliance

Friend for Life photo

@fflcancersprt

Maurer Foundation photo

@MaurerFdn

Dee Sparacio photo

@womenofteal

Alicia C. Staley photo

@stales

Beth L. Gainer photo

@Bethlgainer

Our partner, @AstraZenecaUS announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved by the US FDA for the treatment of adult patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.


Genetic testing affects your children. Learn how Kerith spoke to her children about her positive BRCA test. Watch Kerith’s story: youtube.com/watch?v=p-M3c4… @AstraZenecaUS


Sharsheret stands with Israel and prays for lasting peace.

Tweet Image 1

The @CDCgov’s Div of Cancer Prevention & Control launched the My Family Health Portrait: Cancer app, that helps individuals collect their family’s history of cancer & learn their risk for breast, ovarian & colorectal cancers. The app is available on Google Play & the App Store.


Our partner @SeagenGlobal announces: Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer


News from Sharsheret's partner @AstraZeneca: Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer. ow.ly/2A7Y50OPETe


Congrats to Sharsheret's partner, @GEHealthCare: the NCCN Guidelines now recommend F-18 fluoroestradiol (Cerianna) for ER+ positive mBC systemic staging workup. Read more: ow.ly/U3sE50OI2jf #Sharsheret #GEHealthCare #NCCN #F18fluoroestradiol #Cerianna


Congrats to our partner @pfizer: the U.S. FDA expanded the indication for IBRANCE® (palbociclib) to include its use in combination with an AI as initial endocrine-based therapy for the treatment of HR+/HER2- mBC, regardless of menopausal status.


Sharsheret's Young Professionals Circle Casino Night is back on 12/17 🃏 🎲 Join us for a fun and meaningful evening of casino games, raffle prizes, food and drinks. Hurry! Prices go up on December 1st. 🎰 Register here: link.sharsheret.org/YPCasino

Tweet Image 1

Click to watch as women w/ advanced cancer share inspirational stories, memories, feelings & advice ow.ly/EQ9G50LuL7t. This video series is part of the Living Legacies project made possible w/ generous support from @GileadSciences & in partnership with Memories Live.


Genetic results impact your treatment plan. Learn how Marissa's positive BRCA1 test impacted her breast cancer diagnosis. Watch Marissa's story: youtube.com/watch?v=5-m_Xp… The @sharsheretofficial BRCA Hereditary Cancer video series is made possible w/ support from @Astrazeneca

Tweet Image 1

Sharsheret Reposted

In honor of #BreastCancerAwarenessMonth @Sharsheret’s CEO Elana Silber joined @FLOTUS for the launch of a series of roundtables with @AmericanCancer @Sharsheret is doing such important work to support Jewish women living with breast and ovarian cancer.

Tweet Image 1
Tweet Image 2
Tweet Image 3

Sharsheret Reposted

This #BreastCancerAwarenessMonth, we’re honored to support the work of our grantee, @Sharsheret, one of the nation’s leading Jewish cancer organizations.

Tweet Image 1

Sharsheret goes to the @WhiteHouse! Sharsheret's CEO Elana Silber meets with leaders in the cancer community to launch Cancer Moonshot's National Roundtables on Breast and Cervical Cancer. Follow along as we share snippets from this groundbreaking day.

Tweet Image 1
Tweet Image 2

Sharsheret Reposted

In this month’s blog, @GDbinky, Global Head of Advocacy & Strategic Relations, shares how advocacy groups are meeting the needs of the diverse #BreastCancer community: bit.ly/3CvCYsW @SHAREing @tigerlilycares @SusanGKomen @Sharsheret @LivingBeyondBC


Need tips for managing your work life and cancer diagnosis? Join us at @CancerandCareers virtual West Coast Conference on Work & Cancer cancerandcareers.org/en/westcoast #CACWestCoast

Tweet Image 1

1 in 72 women will develop #ovariancancer in their lifetime. Schedule a free family conference call with our genetic counselor to see how your family history plays a role in your health. 💗Contact us at genetics@sharsheret.org for FREE genetics support. #ovariancancerawareness

Tweet Image 1

If you have questions about hereditary cancer, Peggy is here to help. Please contact us at genetics@sharsheret.org, or call/text Peggy at (201) 661-6867 for FREE genetics support. 💗 P.S. We also offer family conference calls.

Tweet Image 1

Sharsheret partner @SermonixPharma Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant in Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer and an ESR1 Mutation. Read more here: ow.ly/hknp50KI5a8

Tweet Image 1

Moms impacted by breast cancer are feeling desperate and invisible during the infant formula shortage. @LivingBeyondBC recognizes their voices and struggles in this compelling article: lbbc.org/news-opinion/i…


Loading...

Something went wrong.


Something went wrong.